background
human
metapneumoviru
hmpv
pneumoviru
known
caus
respiratori
diseas
children
identifi
pathogen
healthcar
burden
associ
cost
fulli
understood
object
studi
aim
assess
clinic
characterist
children
hmpv
infect
admit
paediatr
intens
care
unit
picu
across
unit
kingdom
uk
nineyear
period
estim
associ
cost
care
studi
design
data
collect
uk
paediatr
intens
care
audit
network
picanet
cost
calcul
use
nation
health
servic
nh
refer
cost
scheme
result
admiss
hmpv
detect
number
admiss
associ
code
hmpv
rose
steadili
studi
period
three
show
signific
season
variabl
peak
season
novemb
may
children
requir
vari
level
intens
care
support
minim
complex
support
includ
invas
ventil
inotrop
renal
replac
therapi
extracorpor
membran
oxygen
ecmo
hmpv
associ
five
death
studi
period
associ
cost
picu
admiss
estim
studi
period
estim
annual
cost
rise
studi
period
due
increas
hmpv
admiss
conclus
hmpv
associ
signific
healthcar
burden
associ
cost
care
picu
uk
human
metapneumoviru
hmpv
pneumoviru
first
identifi
netherland
ubiquit
viru
children
infect
year
age
continu
experi
reinfect
throughout
life
studi
shown
hmpv
identifi
children
clinic
symptom
upper
respiratori
tract
infect
urti
lower
respiratori
tract
infect
lrti
hospitalis
attribut
fraction
hmpv
proport
children
hmpv
detect
hmpv
consid
caus
ill
infect
children
respiratori
symptom
calcul
similar
rsv
influenza
annual
rate
hospitalis
children
year
age
associ
hmpv
approxim
unit
state
us
similar
burden
influenza
lower
rsv
estim
preval
hmpv
within
commun
set
variabl
influenc
cohort
sampl
valu
rang
symptom
urtilrti
studi
children
us
estim
annual
outpati
burden
hmpv
clinic
visit
emerg
depart
visit
per
children
hmpv
show
season
variat
major
infect
detect
januari
april
northern
hemispher
caus
rang
clinic
syndrom
mild
urti
sever
lrti
requir
intens
care
studi
examin
children
present
emerg
depart
milan
itali
found
children
hmpv
infect
present
mild
urti
pharyng
acut
otiti
media
croup
acut
wheez
acut
bronchiol
pneumonia
larg
studi
children
year
age
admit
hospit
respiratori
ill
fever
us
show
children
hmpv
infect
like
need
supplement
oxygen
http
receiv
septemb
receiv
revis
form
novemb
accept
januari
hmpvneg
counterpart
versu
longer
averag
stay
paediatr
intens
care
unit
picu
day
versu
day
studi
compar
characterist
children
admit
picu
hmpv
rsv
found
children
hmpv
like
present
pneumonia
pneumon
rsv
vs
group
requir
similar
level
invas
noninvas
ventil
current
specif
treatment
vaccin
hmpv
infect
given
ubiquit
natur
hmpv
potenti
clinic
sever
high
burden
diseas
becom
increasingli
import
establish
impact
hmpv
paediatr
popul
studi
aim
assess
clinic
characterist
children
hmpv
infect
admit
picu
unit
kingdom
uk
nineyear
period
secondari
aim
estim
associ
cost
care
data
extract
retrospect
uk
paediatr
intens
care
audit
network
picanet
databas
children
hmpv
diagnost
code
januari
decemb
picanet
uk
nation
databas
includ
clinic
laboratori
data
almost
children
admit
picu
uk
estim
case
ascertain
data
collect
includ
basic
demograph
inform
time
admiss
length
picu
stay
primari
diagnosi
microbiolog
result
intens
care
support
requir
paediatr
index
mortal
score
sever
score
system
use
help
predict
outcom
patient
admit
picu
mortal
although
detect
hmpv
record
diagnost
code
includ
children
data
avail
organ
detect
ie
whether
collect
upper
lower
respiratori
tract
diagnost
test
use
addit
presenc
hmpv
may
primari
reason
admiss
picu
may
incident
find
healthcar
cost
calcul
use
nh
refer
cost
scheme
healthcar
cost
present
mean
data
order
preserv
total
cost
critic
care
uk
divid
basic
intermedi
advanc
within
advanc
critic
care
sublevel
picanet
current
collect
data
children
basic
intermedi
critic
care
thu
patient
includ
studi
receiv
least
advanc
critic
care
level
document
royal
colleg
paediatr
child
health
rcpch
paediatr
critic
care
outlin
sublevel
advanc
critic
care
howev
full
detail
care
children
receiv
stay
picu
avail
picanet
eg
volum
fluid
bolus
receiv
thu
could
differenti
admiss
need
level
care
requir
ecmo
requir
level
care
therefor
calcul
mean
minimum
maximum
cost
admiss
requir
level
care
requir
level
care
proport
compar
use
chi
squar
fisher
exact
test
continu
variabl
test
normal
use
shapirowilk
test
data
analys
use
either
independ
ttest
mannwhitney
u
test
appropri
statist
analysi
carri
microsoft
excel
ibm
spss
statist
version
new
york
usa
ethic
approv
requir
studi
admiss
involv
patient
studi
period
studi
period
picanet
estim
total
number
admiss
uk
picu
would
mean
admiss
associ
hmpv
contribut
approxim
total
picu
admiss
per
picu
admiss
patient
one
admiss
five
patient
two
admiss
three
patient
three
admiss
patient
male
mean
standard
deviat
sd
age
admiss
year
median
rang
age
month
year
mean
sd
length
stay
day
median
rang
day
number
patient
code
hmpv
increas
gradual
three
fig
number
case
per
month
highest
novemb
may
case
occur
month
fig
peak
number
case
april
saw
case
studi
period
five
case
identifi
januari
despit
higher
number
case
month
either
side
patient
hmpv
alon
detect
remaind
patient
anoth
organ
also
detect
includ
adenoviru
rhinoviru
rsv
coronaviru
parainfluenza
viru
group
streptococcu
differ
diagnos
record
primari
diagnosi
picu
admiss
respiratorybas
diagnosi
common
admiss
tabl
children
varieti
intens
care
requir
includ
invas
noninvas
ventil
inotrop
support
renal
replac
therapi
extracorpor
membran
oxygen
ecmo
mani
children
requir
one
type
support
either
sequenti
simultan
ten
children
requir
none
intervent
requir
one
intervent
requir
two
intervent
nine
requir
three
intervent
tabl
paediatr
index
mortal
score
mortal
score
give
valu
mortal
risk
base
event
within
first
hour
admiss
picu
collect
admiss
mean
sd
mortal
risk
median
rang
five
children
die
mean
sd
predict
mortal
rate
children
compar
predict
mortal
among
surviv
discharg
p
die
requir
invas
ventilatori
support
four
requir
inotrop
support
primari
record
diagnos
die
acut
bronchiol
acut
obliter
bronchiol
lower
respiratori
tract
infect
sepsi
cardiac
arrest
unsuccess
resuscit
cost
care
estim
use
nh
refer
cost
scheme
advanc
critic
care
level
cost
level
cost
level
cost
level
cost
level
cost
mean
minimum
maximum
cost
tabl
combin
intens
care
support
requir
data
present
n
mean
sd
admiss
requir
level
care
n
mean
cost
admiss
requir
level
care
n
total
cost
picu
admiss
studi
period
estim
give
annual
estim
minimum
cost
maximum
cost
studi
period
howev
number
hmpv
case
increas
significantli
studi
period
cost
estim
minimum
cost
maximum
cost
increas
minimum
cost
maximum
cost
hmpv
detect
increas
frequenc
amongst
uk
picu
popul
may
due
increas
incid
viru
howev
like
attribut
increas
awar
hmpv
potenti
pathogen
therefor
increas
test
specif
well
increas
use
multiplex
polymeras
chain
reaction
pcr
test
detect
multipl
pathogen
singl
sampl
possibl
explan
includ
six
new
picu
total
began
ad
data
unit
picanet
cours
studi
overal
increas
picu
admiss
uk
studi
period
ubiquit
natur
hmpv
demonstr
equal
gender
spread
wide
age
rang
affect
patient
also
clear
hmpv
season
variat
incid
peak
season
occur
novemb
may
maxim
incid
occur
april
similar
season
pattern
shown
studi
northern
hemispher
season
note
rang
novemb
may
peak
occur
februari
april
interestingli
found
case
januari
despit
case
month
either
side
may
due
fact
januari
peak
season
rsv
influenza
test
may
predominantli
focuss
pathogen
especi
earli
year
studi
investig
type
support
requir
children
whilst
admit
picu
requir
respiratori
support
requir
inotrop
renal
replac
therapi
andor
ecmo
two
patient
requir
ecmo
one
primari
diagnosi
acut
viral
bronchiol
viral
pneumonia
patient
hmpv
code
sole
infect
organ
mortal
studi
group
five
children
four
hmpv
identifi
one
also
rhinoviru
detect
five
children
requir
invas
respiratori
support
four
requir
inotrop
none
children
die
receiv
renal
replac
therapi
ecmo
three
respiratoryrel
primari
diagnos
includ
acut
bronchiol
lower
respiratori
tract
infect
impli
hmpv
primari
caus
death
children
unawar
previou
studi
systemat
measur
hmpv
mortal
rate
data
demonstr
hmpv
caus
sever
respiratori
diseas
requir
highest
level
intens
care
support
even
death
hmpv
place
signific
financi
burden
nh
potenti
cost
million
per
year
inclus
children
admit
picu
thu
true
cost
healthcar
episod
associ
hmpv
much
higher
studi
us
estim
mean
healthcar
cost
annual
us
million
hospitalis
associ
hmpv
hmpv
per
picu
admiss
appear
account
consider
smaller
burden
picu
servic
compar
rsv
influenza
similar
studi
use
picanet
data
look
picu
admiss
relat
influenza
octob
march
show
averag
picu
admiss
per
year
assum
averag
picu
admiss
per
year
would
account
approxim
per
picu
admiss
similar
data
uk
picu
admiss
relat
rsv
avail
howev
one
studi
investig
caus
bronchiol
admiss
uk
picu
known
approxim
bronchiol
admiss
caus
rsv
consid
picu
admiss
bronchiol
infant
year
alon
attribut
rsv
within
cohort
would
approxim
per
picu
admiss
true
burden
rsv
admiss
includ
older
children
far
higher
routin
frequent
test
hmpv
rsv
influenza
burden
hmpv
may
continu
increas
studi
sever
strength
limit
describ
burden
hmpv
infect
picu
nation
level
nineyear
period
calcul
associ
healthcar
cost
line
similar
studi
use
code
data
signific
limit
studi
fact
case
hmpv
may
incident
find
children
admit
picu
reason
case
may
incorrectli
code
thu
lead
either
overor
underestim
true
number
case
place
restrict
conclus
drawn
hmpv
caus
organ
clinic
characterist
observ
addit
children
anoth
infect
pathogen
code
addit
hmpv
stay
howev
patient
hmpv
code
picu
stay
patient
respiratorybas
primari
diagnosi
suggest
hmpv
reason
picu
admiss
mani
children
data
serv
show
hmpv
caus
sever
infect
children
age
although
primarili
young
children
hmpv
consid
signific
pathogen
viru
alongsid
rsv
influenza
potenti
caus
signific
morbid
even
mortal
among
children
may
result
cost
nh
million
per
year
picu
set
alon
effort
made
develop
treatment
prophylact
agent
help
clinician
prevent
manag
children
hmpv
infect
requir
none
declar
